🇺🇸 FDA
Pipeline program

ELEVIDYS

SRP-9001-402

Approved small_molecule active

Quick answer

ELEVIDYS for Duchenne Muscular Dystrophy is a Approved program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Sarepta Therapeutics
Indication
Duchenne Muscular Dystrophy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials